相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-Term Antihypertensive Efficacy and Safety of the Oral Direct Renin Inhibitor Aliskiren A 12-Month Randomized, Double-Blind Comparator Trial With Hydrochlorothiazide
Roland E. Schmieder et al.
CIRCULATION (2009)
Salt-Resistant and Salt-Sensitive Phenotypes Determine the Sensitivity of Blood Pressure to Weight Loss in Overweight/Obese Patients
Irene S. Hoffmann et al.
JOURNAL OF CLINICAL HYPERTENSION (2008)
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial
Karl Andersen et al.
JOURNAL OF HYPERTENSION (2008)
Interindividual variation in serum sodium and longitudinal blood pressure tracking in the Framingham Heart Study
Rodrigo M. Lago et al.
JOURNAL OF HYPERTENSION (2008)
Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension
Yagiz Uresin et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2007)
Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial
Suzanne Oparil et al.
LANCET (2007)
Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension
Byung-Hee Oh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Renin inhibition with aliskiren provides additive anti hypertensive efficacy when used in combination with hydrochlorothiazide
Alberto Villamil et al.
JOURNAL OF HYPERTENSION (2007)
2007 ESH-ESC guidelines for the management of arterial hypertension - The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC)
Giuseppe Mancia et al.
BLOOD PRESSURE (2007)
Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-Month results of a randomized trial
PJ Elmer et al.
ANNALS OF INTERNAL MEDICINE (2006)
Recommendations for blood pressure measurement in humans and experimental animals - Part 1: Blood pressure measurement in humans - A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research
TG Pickering et al.
HYPERTENSION (2005)
Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption
M Azizi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee guidelines
YF Wang et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
Structure-based design of aliskiren, a novel orally effective renin inhibitor
JM Wood et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren
A Stanton et al.
HYPERTENSION (2003)
A low-sodium diet potentiates the effects of losartan in type 2 diabetes
CA Houlihan et al.
DIABETES CARE (2002)
Importance of the renin system for determining blood pressure fall with acute salt restriction in hypertensive and normotensive whites
FJ He et al.
HYPERTENSION (2001)
Different associations of blood pressure with 24-hour urinary sodium excretion among pre- and post-menopausal women
Y Yamori et al.
JOURNAL OF HYPERTENSION (2001)
National Heart, Lung, and Blood Institute workshop on sodium and blood pressure - A critical review of current scientific evidence
AV Chobanian et al.
HYPERTENSION (2000)
Prognostic value of ambulatory blood pressure - Current evidence and clinical implications
P Verdecchia
HYPERTENSION (2000)
分享论文
